Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians

Journal of Medical Genetics

Volumn 42, Issue 10, 2005, Pages 749-755

  Wideroff, L ^a   Vadaparampil, S T ^b   Greene, M H ^a   Taplin, S ^a   Olson, L ^c   Freedman, A N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c ABT ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RESEARCH; CLINICAL PRACTICE; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; GENERAL PRACTITIONER; GYNECOLOGY; HUMAN; HUMAN EXPERIMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONCOGENE; OVARY CANCER; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SURGEON; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PHYSICIANS;

EID: 26944439058     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.030296     Document Type: Article

References (42)

1. Thull DL, Vogel VG. Recognition and management of hereditary breast cancer syndromes. Oncologist 2004;9:13-24.
2. Annie Yu HJ, Lin KM, Ota DM, Lynch HT. Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev 2003;29:461-70.
3. Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004;41:81-91.
4. Hofman KJ, Tambor ES, Chase GA, Geller G, Faden RR, Holtzman NA. Physicians' knowledge of genetics and genetic tests. Acad Med 1993;68:625-32.
5. Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT. Screening adherence in BRCA1/2 families is associated with primary care physicians' behavior. Am J Med Genet 2004;125A:5-11.
6. Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Finch C, Magnant C, Pennanen M, Tsangaris T, Willey S, Isaacs C. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 2004;22:1823-9.
7. Wideroff L, Freedman AN, Olson L, Klabunde CN, Davis W, Srinath KP, Croyle RT, Ballard-Barbash R. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev 2003;12:295-303.
8. Freedman AN, Wideroff L, Olson L, Davis W, Klabunde C, Srinath KP, Reeve BB, Croyle RT, Ballard-Barbash R. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet 2003;120A:63-71.
9. Li FP. Translational research on hereditary colon, breast, and ovarian cancers. Monogr Natl Cancer Inst 1995;17:1-4.
10. Carter CL, Scott JA, Glauber PM, Murphy PD. The Oncormed approach to genetic testing. Genet Test 1997;1:137-44.
11. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, Booker SV, Parker RD, Hamilton SR. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-7.
12. Shah BV, Barnwell BG, Beiler GS. SUDAAN user's manual, Release 7.5. Research Triangle Park, NC: Research Triangle Institute, 1997.
13. Jacobellis J, Martin L, Engel J, Van Eenwyk J, Bradley L, Kassim S, Jorgenson C, Litch J, Myers M. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing-Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2004;53:603-6.
14. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ. Awareness of family health history as a risk factor for disease-United States, 2004. MMWR Morb Mortal Wkly Rep 2004;53:1044-7.
15. Mouchawar J, Klein C, Mullineaux L. Colorado family physicians' knowledge of hereditary breast cancer and related practice. J Cancer Educ 2001;16:33-7.
16. Sifri R, Myers R, Hyslop T, Turner B, Cocroft J, Rothermel T, Grana J, Schlackman N. Use of cancer susceptibility testing among primary care physicians. Clin Genet 2003;64:355-60.
17. Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol 2003;97:729-33.
18. Wilkins-Haug L, Hill LD, Power ML, Holzman GB, Schulkin J. Gynecologists' training, knowledge, and experiences in genetics: a survey. Obstet Gynecol 2000;95:421-4.
19. Escher M, Sappino AP. Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 2000;11:1131-5.
20. Pichert G, Dietrich D, Moosmann P, Zwahlen M, Stahel RA, Sappino AP. Swiss primary care physicians' knowledge, attitudes, and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2003;2:153-8.
21. Julian-Reynier C, Eisinger F, Moatti JP, Sobol H. French physicians' knowledge about hereditary breast/ovarian cancer: the need for continuing vocational education in genetics. Community Genet 1999;2:165-72.
22. Yong MC, Zhou XJ, Lee SC. The importance of paternal family history in hereditary breast cancer is underappreciated by health care professionals. Oncology 2003;64:220-6.
23. Hunter A, Wright P, Cappelli M, Kasaboski A, Surh L. Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clin Genet 1998;53:447-55.
24. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami A, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
25. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
26. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-406.
27. American College of Medical Genetics/American Society of Human Genetics. Genetic testing for colon cancer: joint statement of the American College of Medical Genetics and American Society of Human Genetics. Genet Med 2000;2:362-6.
28. American Gastroenterological Association. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:195-7.
29. National Comprehensive Cancer Network. Genetic/familial high-risk screening. Practice Guidelines in oncology, version 1.2004. www.nccn.org/ index.html. Accessed 9 August, 2004.
30. Schroy PC 3rd, Barrison AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 2002;97:1031-6.
31. Terdiman JP. HNPCC: an uncommon but important diagnosis. Gastroenterology 2001;121:1005-8.
32. Blazer KR, Grant M, Sand SR, MacDonald DJ, Uman GC, Weitzel JN. Effects of a cancer genetics education programme on clinician knowledge and practice. J Med Genet 2004;41:518-22.
33. Lapham EV, Kozma C, Weiss JO, Benkendorf JL, Wilson MA. The gap between practice and genetics education of health professionals: HuGEM survey results. Genet Med 2000;2:226-31.
34. Burke W, Emery J. Genetics education for primary care providers. Nat Rev Genet 2002;3:561-6.
35. Haas JS, Kaplan CP, Gregorich SE, Perez-Stable EJ, Des Jarlais G. Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk? J Gen Intern Med 2004;19:302-9.
36. Winkler JD, Lohr KN, Brook RH. Persuasive communication and medical technology assessment. Arch Intern Med 1985;145:314-17.
37. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Rubenstein LZ, Shekelle PG. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002;136:041-51.
38. Worthen HG. Inherited cancer and the primary care physician; barriers and strategies. Cancer 1999;86:2583-8S.
39. Koil CE, Everett JN, Hoechstetter L, Ricer RE, Huelsman KM. Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genet Med 2003;5:364-9.
40. Bouchard L, Blancquaert I, Eisinger F, Foulkes WD, Evans G, Sobol H, Julian-Reynier C. Prevention and genetic testing for breast cancer: variations in medical decisions. Soc Sci Med 2004;58:1085-96.
41. Walsh JME, McPhee SJ. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Ed Q 1992;19:157-75.
42. Mouchawar J, Valentine Goins K, Somkin C, Puleo E, Hensley Alford S, Geiger AM, Taplin S, Gilbert J, Weinmann S, Zapka J. Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs. Genet Med 2003;5:444-50.